Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Double-Blind Control Trial Evaluating the Utility of Continuous Positive Airway Pressure (CPAP) in the Treatment of High Altitude Pulmonary Edema (HAPE)

NCT04186598 is registered in ClinicalTrials.gov with CommonSpirit Health as lead sponsor.

NCT NCT04186598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04186598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Double-Blind Control Trial Evaluating the Utility of Continuous Positive Airway Pressure (CPAP) in the Treatment of High Altitude Pulmonary Edema (HAPE)
Lead sponsor
CommonSpirit Health
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2020
Completion date
September 13, 2023
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

continuous positive airway pressure, high altitude pulmonary edema